Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study

Matthias Hepprich, Justus Fischer, Marco Cattaneo, Antonio Ferreira, David Herzig, Lia Bally, Marc Donath

Open source

DOI: 10.1136/bmjopen-2024-097981
Published: 2025-05
Container: BMJ Open
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2024-097981,
  title = {Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study},
  author = {Matthias Hepprich and Justus Fischer and Marco Cattaneo and Antonio Ferreira and David Herzig and Lia Bally and Marc Donath},
  year = {2025},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2024-097981},
  url = {https://doi.org/10.1136/bmjopen-2024-097981}
}

RIS

TY  - JOUR
TI  - Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study
AU  - Matthias Hepprich
AU  - Justus Fischer
AU  - Marco Cattaneo
AU  - Antonio Ferreira
AU  - David Herzig
AU  - Lia Bally
AU  - Marc Donath
PY  - 2025
JO  - BMJ Open
DO  - 10.1136/bmjopen-2024-097981
UR  - https://doi.org/10.1136/bmjopen-2024-097981
ER  -

APA

Hepprich, M., Fischer, J., Cattaneo, M., Ferreira, A., Herzig, D., Bally, L., & Donath, M. (2025). Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study. BMJ Open. https://doi.org/10.1136/bmjopen-2024-097981

Source records

crossref · retrieved 2026-09-27T05:41:05.474Z